DOSSIER · 13F Holders · Q2 2026
XLO
XILIO THERAPEUTICS INC
27 institutions still hold XILIO THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 98422T209·27 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
27 institutions reported XLO in Q2 2026. Bain Capital Life Sciences Investors, LLC leads at 23.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
7 more holders available. Log in →